| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 97.040 | - | 25.787 | 48.662 | 36.509 | 96.066 | 107.337 | 101.160 | 49.270 |
| Total Income - EUR | - | 98.086 | - | 25.822 | 48.234 | 36.862 | 100.616 | 116.173 | 110.909 | 53.943 |
| Total Expenses - EUR | - | 18.540 | - | 24.988 | 47.851 | 108.944 | 156.311 | 158.125 | 157.790 | 59.985 |
| Gross Profit/Loss - EUR | - | 79.546 | - | 834 | 383 | -72.082 | -55.695 | -41.952 | -46.881 | -6.041 |
| Net Profit/Loss - EUR | - | 66.819 | - | 663 | 41 | -72.082 | -55.695 | -41.952 | -46.881 | -6.041 |
| Employees | - | 2 | - | 1 | 1 | 2 | 3 | 3 | 3 | 0 |
Check the financial reports for the company - Senera Pharma Medical S.a.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | - | 0 | 0 | 1.981 | 4.242 | 3.078 | 1.990 | 1.011 |
| Current Assets | - | 99.555 | - | 61.309 | 84.504 | 85.043 | 94.321 | 131.180 | 99.699 | 76.036 |
| Inventories | - | 0 | - | 4.060 | 9.755 | 49.411 | 49.002 | 69.630 | 17.422 | 0 |
| Receivables | - | 97.596 | - | 54.724 | 74.296 | 34.171 | 45.194 | 60.890 | 80.627 | 75.606 |
| Cash | - | 1.960 | - | 2.526 | 452 | 1.461 | 125 | 660 | 1.650 | 430 |
| Shareholders Funds | - | 73.499 | - | 45.687 | 44.843 | -28.089 | -83.955 | -126.168 | -173.509 | -178.581 |
| Social Capital | - | 6.680 | - | 21.489 | 21.073 | 20.674 | 20.215 | 20.278 | 20.216 | 20.103 |
| Debts | - | 26.056 | - | 15.622 | 39.660 | 115.113 | 182.518 | 260.426 | 275.198 | 255.629 |
| Income in Advance | - | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Senera Pharma Medical S.a.